Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERTUGLIFLOZIN PIDOLATE vs ERYTHROMYCIN: Safety Overview

Metric ERTUGLIFLOZIN PIDOLATE ERYTHROMYCIN
Total FAERS Reports 681 7,325
Deaths Reported 4 467
Death Rate 0.6% 6.4%
Hospitalizations 128 1,213
Average Patient Age 57.0 yrs 53.9 yrs
% Female Patients 56.1% 79.8%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Merck Sharp & Dohme LLC Bryant Ranch Prepack
Route ORAL TOPICAL
Marketing Status N/A Discontinued